Current Treatment of Hepatitis C in the Era of New Medications

Module number
Date presented
October 31, 2017 
CE Credit

On Tuesday, October 31st, Dr. Ayse Aytaman of the Veterans Health Administration presented on: “Current Treatment of Hepatitis C in the Era of New Medications”

Presenter Bio:
Dr. Ayse Aytaman earned her medical degree from the University of Vienna, where she studied with a full scholarship from the Austrian Ministry of Education. After her residency and fellowship in gastroenterology and hepatology at SUNY Health Science Center at Brooklyn, she joined the faculty at VA New York Harbor HCS in Brooklyn. She created the first multidisciplinary viral hepatitis team in 1999 with inclusion of pharmD and liver psychology in the VA system. In 2012, with a grant from VA Public Health, she established the first multi-facility and multidisciplinary, VISN-wide hepatocellular carcinoma team and SCAN ECHO liver cancer tumor board in the nation, utilizing heavily telehealth/virtual telemedicine technology.
Dr. Aytaman is also organizes the yearly national liver cancer summits since 2012 for the VA providers.
Dr. Aytaman’s clinical research interest areas are epidemiology and outcomes research in advanced liver diseases, hepatocellular carcinoma, system-based performance improvement in chronic and advanced liver diseases and pre- and post-transplant hepatitis C therapy.

Access the slides here